Elham Masoumi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Elham Masoumi

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Parasite Immunology|January 26, 2024

The effects of Fasciola hepatica recombinant proteins (peroxiredoxin and cathepsin L1) on Crohn's disease experimental modelHamid Hasanpour, Reza Falak, Kobra Mokhtarian, et al.

Science Advances|July 4, 2025

A universal chimeric antigen receptor (CAR)-fragment antibody binder (FAB) split system for cancer immunotherapyAinhoa Arina, Edwin Arauz, Elham Masoumi, et al.

Iranian Journal of Public Health|June 29, 2021

SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A ReviewMahdi Zavvar, Hamid Emadi Kochak, Kamal Abdolmohammadi, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Parasite Immunology|January 26, 2024

The effects of Fasciola hepatica recombinant proteins (peroxiredoxin and cathepsin L1) on Crohn's disease experimental modelHamid Hasanpour, Reza Falak, Kobra Mokhtarian, et al.

Science Advances|July 4, 2025

A universal chimeric antigen receptor (CAR)-fragment antibody binder (FAB) split system for cancer immunotherapyAinhoa Arina, Edwin Arauz, Elham Masoumi, et al.

Iranian Journal of Public Health|June 29, 2021

SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A ReviewMahdi Zavvar, Hamid Emadi Kochak, Kamal Abdolmohammadi, et al.

Pageof 3